ComplianceOnline

FDA Challenges Dietary Supplement Makers on Marketing of DMAA Products

  • By: Staff Editor
  • Date: July 13, 2012
Webinar All Access Pass Subscription Abstract:

The FDA, which regulates dietary supplement products and their ingredients, recently warned manufacturers of dietary supplements containing DMAA (1, 3-dimethylamylamine) for not providing evidence regarding safety of their products. The Agency thus deemed the products as 'adulterated' (as DMAA is known to cause serious side-effects) and sent warning letters to 10 manufacturing firms for failing to demonstrate the safety of their products.

Bookmark and Share

Compliance Trainings

Marketing and Advertising Compliance - The First UDAAP Hotspot
By - Kara Lamphere
On Demand Access Anytime
Marketing for Most of Us Today
By - Barney Kramer
On Demand Access Anytime
Sales Principles for Small and Medium Businesses
By - Barney Kramer
On Demand Access Anytime
The Core of Program Management Across Sectors
By - Samir Penkar
On Demand Access Anytime

Compliance Standards

Best Sellers
You Recently Viewed
    Loading